RocketTickers

FDA grants accelerated approval for ADUHELM™ as the first and on

Long
NASDAQ:BIIB   Biogen Inc
BIIB: Biogen Inc .
2021-06-07 13:00:00
FDA grants accelerated approval for ADUHELM™ as the first and only Alzheimer’s disease treatment to address a defining pathology of the disease
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.